Safety and Efficacy of Olopatadine HCl Nasal Spray in 6-11 Year Old Patients.
Phase of Trial: Phase III
Latest Information Update: 11 Nov 2017
At a glance
- Drugs Olopatadine (Primary)
- Indications Seasonal allergic rhinitis
- Focus Therapeutic Use
- Sponsors Alcon
- 02 Mar 2010 Results presented at the 66th Annual Meeting of the American Academy of Allergy, Asthma and Immunology
- 11 Feb 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 11 Feb 2010 Actual patient number changed from 1188 to 2388 as reported by ClinicalTrials.gov.